B, consensus $1.44B. Sees Q1 gross margin 36%-39%. Sees Q1 capital expenditures $20M-$25M. Sees FY25 capital expenditures $75M-$95M. The company said, “Contract talent solutions exited the fourth ...
West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2024 ...
HERNDON, Va., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) today posted its 2024 fourth quarter financial results. Complete financial results are available on the company’s website at ...
Flushing Financial Corporation ( NASDAQ: FFIC) Q4 2024 Earnings Conference Call January 29, 2025 9:30 AM ET John Buran - President and CEO Susan Cullen - Senior EVP, CFO and Treasurer Mark Fitzgibbon ...